These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 33968794)

  • 21. An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Roe K
    Neurochem Res; 2022 Mar; 47(3):517-530. PubMed ID: 34669122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
    Romo-Vaquero M; Fernández-Villalba E; Gil-Martinez AL; Cuenca-Bermejo L; Espín JC; Herrero MT; Selma MV
    Food Funct; 2022 Jun; 13(11):6306-6316. PubMed ID: 35611932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral and intestinal dysbiosis in Parkinson's disease.
    Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
    Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
    Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
    Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
    Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
    Manfready RA; Goetz CG; Keshavarzian A
    Int Rev Neurobiol; 2022; 167():81-99. PubMed ID: 36427960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
    van Kessel SP; El Aidy S
    J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
    Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK
    J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease.
    Hasuike Y; Endo T; Koroyasu M; Matsui M; Mori C; Yamadera M; Fujimura H; Sakoda S
    Med Hypotheses; 2020 Jan; 134():109436. PubMed ID: 31678900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis.
    Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J
    ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's Disease and Gut Microbiota.
    Hirayama M; Ohno K
    Ann Nutr Metab; 2021; 77 Suppl 2():28-35. PubMed ID: 34500451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics.
    Ternák G; Kuti D; Kovács KJ
    Med Hypotheses; 2020 Apr; 137():109564. PubMed ID: 31954994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
    Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
    Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
    Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
    Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explore the Effects of Fe₃O₄ Nanoparticles and Oxidative Stress and Neuroinflammatory Responses on the Intestinal Flora Based on a Parkinson Rat Model.
    Xu L; Mayila T; Wang J
    J Nanosci Nanotechnol; 2021 Feb; 21(2):1176-1183. PubMed ID: 33183459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease mechanisms as subtypes: Microbiome.
    Bonvegna S; Cilia R
    Handb Clin Neurol; 2023; 193():107-131. PubMed ID: 36803806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease.
    Vuuren MJV; Nell TA; Carr JA; Kell DB; Pretorius E
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33383805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.